Targeting the window of opportunity in management of hidradenitis suppurativa
22 Jan 2024
byDr. Han-Chi Tseng
Department of Dermatology
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung, Taiwan
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease associated with systemic comorbidities and diminished health-related quality of life (HRQoL). At the Hong Kong Society of Dermatology and Venereology Annual Scientific Meeting 2023, Dr Han-Chi Tseng of the Department of Dermatology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan, reviewed the burden of HS, evidence for treatment with secukinumab, and the potential for early treatment initiation to change the disease course.
